GSK-207660

Study Sponsor: GSK

Study Title

A phase III study (a placebo controlled, randomized, double-blind comparative study and an open-label, uncontrolled study) to evaluate the efficacy and safety of GSK1358820 in patients with post-stroke upper limb spasticity

Medicine or Vaccine (generic name)

OnabotulinumtoxinA

Sponsor Identification Number

207660

Trial Registry Identification Number(#'s)

NCT03261167

Medical Condition

Spasticity, Post-Stroke

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=207660

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03261167

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2020